HSU News Feed

29 July 2021

HSU recently completed their first commercial contract, genotyping 284 samples using the Illumina Global Screening Array-24 v3.0 BeadChips. We are happy to report that 99% of samples passed genotyping QC.

20 November 2020

HSU has recently completed a project to extract DNA and perform genome wide methylation screening using the Illumina MethylationEPIC assay on 366 samples from the Staged Treatment in Early Psychosis (STEP) project. All samples passed our in-house QC checks and are now undergoing further analysis.

26 October 2020

HSU have recently completed the Illumina MethylationEPIC array on 826 samples for a project investigating epigenetic changes in patients with Alzheimer's Disease. We are happy to report that all samples passed our standard QC.

24 September 2020

We are proud to announce that thanks to our recent iScan Windows 10 computer upgrade, we have reduced our Illumina BeadChip scan time by approximately half! We would like to thank the Institute for Molecular Biosciences for their financial contribution.

01 September 2020

We are excited to launch our latest research project on Endometriosis.
"Endometriosis: Pathogenesis And Treatment Response"
A Collaboration between The Royal Brisbane and Women’s Hospital and the Institute for Molecular Biosciences.

04 August 2020

The lab team are about halfway through completing the Illumina MethylationEPIC arrays for a project investigating epigenetic changes in patients with Alzheimer’s Disease. This project is a continuation of another project we worked on 2 years ago looking at baseline samples for this cohort of people (BrainMend). This latest batch of DNA samples are from the second and third timepoint that these patients were assessed. The epigenetic data from both projects will be analysed together and compared to investigate any changes to the methylation status of DNA over time and how this may influence the disease or vice versa. So far, 4 plates of samples (~380) have been completed with the fifth plate currently in progress.

28 July 2020

Over the last several weeks the HSU team have been busy extracting the DNA from 345 participant samples for the STEP (Staged Treatment in Early Psychosis) project, obtaining good-quality DNA which after further laboratory QC will be taken forward onto the Illumina MethylationEPIC arrays in early September 2020.

26 June 2020

In June, 189 MND samples collected from participants across Australia and New Zealand were genotyped using the new Illumina Global Screening Array-24 v3.0 BeadChips, producing excellent call rates with an average >99%.

09 June 2020

The Human Studies Unit is now back to full operations and we are now able to receipt all your research samples.

Australia Post is doing a great job of reducing their transit times so we are quite confident we will receive your samples within our optimal processing window.

Any questions please contact us on:

09 June 2020

The HSU laboratory genotyped 110 Motor Neurone Disease DNA samples as part of a pilot study using Illumina’s new Infinium Global Diversity Array-8 v1.0 BeadChips targeting over 1.8 million variants! This run produced exceptional results with the average call rate over 99.7%.

19 May 2020

We are back in the lab and the HSU team is getting ready to start receiving your research samples again.

As of now we can receipt your saliva collection kits for extraction or extracted DNA samples for genomics.

From 1st June 2020 we will be able to extend our receipt and processing to whole blood samples, stool and urine.

Any questions please contact us on:

27 March 2020

HSU has completed a project to extract DNA and generate genomic data from 152 saliva samples collected by Dr Dominic Tran, University of Sydney. Dr Tran is studying the effects of transcranial magnetic stimulation (TMS) on movement. HSU received the saliva samples that were collected using the Oragene Saliva collection kits. DNA was extracted from the 2ml saliva samples, DNA concentration measured and finally samples were normalised to ~100ng/ul. All 152 DNA samples were run on Illumina Global Screening Array generating data for ~650,000 snps across the genome for each individual. The average call rate for the samples was 99%.

04 February 2020

In February 2020, our laboratory genotyped 332 DNA samples using the Illumina PsychArray-24 BeadChips as part of a project researching the Biomarkers of Anxiety Disorders and Prediction of Treatment Response. The samples included in this project resulted in an average call rate of >0.98.

25 November 2019

Over the last month, 190 samples were run on the Illumina MethylationEPIC array. Samples were incorporated from a variety of projects including Motor Neurone Disease, Parkinson’s Disease, and the Queensland Twin and Adolescent Brain study. Our lab is happy to report the majority of samples (including all MND samples) passed our standard QC.

11 October 2019

Recently the HSU laboratory genotyped a number of samples from the Early Psychosis, Endometriosis, Endometrial Cell Lines, and Outcomes of Mental Health projects using the Illumina Global Screening Array-24 BeadChips, with the majority of samples producing pass rates of over 98%.

20 August 2019

Starting August 2nd, 475 DNA samples have been genotyped on Illumina® OmniExpress-24 BeadChips as part of the endometriosis disease stratification and risk prediction project. DNA samples originated from the Reproductive Sciences Laboratory at the San Raffaele Scientific Institute in Milan, Italy, and The Royal Women’s Hospital in Melbourne, Australia. This project introduced a new Illumina beadchip into our lab and we are happy to report pass rates of >98% for all samples.

30 June 2019

We have completed the whole genome methylation screening of our Autism CRC cohort. We processed 475 samples using the Illumina Epic arrays in record time. We started 13 May 2019 and were all done by 28 June 2019 – 6 weeks running time allowing for time away on our HSU retreat.

17 June 2019

Last week the HSU team attended an overnight retreat on North Stradbroke Island. We each presented a short talk about our area of expertise, and we completed workshops on human ethics, project planning and data management. We also enjoyed watching the humpback whales on their annual migration past the island.

05 June 2019

Over the last 3 years, between 23/3/2016 and 31/5/2019 we have processed a total of 4286 blood, 759 stool, 660 hair, 1010 urine and 345 saliva samples across 12 projects. Our busiest month was April 2018 when we receipted and processed 211 blood, 56 stool, 90 hair and 29 saliva samples.

31 May 2019

The 2015 – 2019 SALSA project funded by the MND Australia Ice Bucket Challenge Grant came to an end today. During the project we deposited blood samples from 651 MND cases, 230 controls, a total of 1967 sample collections and storage of > 22,000 sample aliquots. The work of the SALSA project will be continued by the NHMRC Partnership Grant.

30 April 2019

During the first quarter of 2019 we receipted and processed 214 blood, 81 stool, 44 urine and 44 saliva samples across seven research projects.

18 April 2019

We have just completed a GWAS (Genome-Wide Association Study) for Endometriosis, using samples from 3 Endometriosis projects. In total we processed 553 samples with an Average Call Rate of 0.99 (range 0.975-0.999).

31 January 2019

We have just completed a GWAS for Autism. We processed a total of 2490 samples.

31 December 2018

A total of 231 new SALSA participants were recruited into this project in 2018. 93 from Victoria, 61 from Queensland, 39 from Western Australia, 20 from South Australia and 18 from New South Wales.

28 September 2018

Our MND Cognition project was launched. This project is conducted by Prof. Gail Robinson and Amelia Ceslis through the RBWH MND Research Clinic under the direction of Dr. Robert Henderson.